Αρχειοθήκη ιστολογίου

Παρασκευή 23 Μαρτίου 2018

The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: A systematic review and economic evaluation

Huxley, N; Crathorne, L; Varley-Campbell, J; Tikhonova, I; Snowsill, T; Briscoe, S; Peters, J; ... Hoyle, M; + view all Huxley, N; Crathorne, L; Varley-Campbell, J; Tikhonova, I; Snowsill, T; Briscoe, S; Peters, J; Bond, M; Napier, M; Hoyle, M; - view fewer (2017) The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: A systematic review and economic evaluation. [Review]. Health Technology Assessment , 21 (38) V-241. 10.3310/hta21380 . Green open access

http://ift.tt/2HZ7WvI

Αναρτήθηκε από στις

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Εγγραφή σε: Σχόλια ανάρτησης (Atom)